Suggestions

Du même auteur

Confounding mitigation for the exposure‐response relationship of bevacizumab in colorectal cancer patients

Archive ouverte | Lobet, Sarah | CCSD

International audience. Aims The exposure‐response relationship of bevacizumab may be confounded by various factors, including baseline characteristics, time‐dependent target engagement and recursive relationships b...

Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients

Archive ouverte | Azzopardi, Nicolas | CCSD

International audience. An ancillary phase II study was conducted to study interindividual variability in cetuximab pharmacokinetics and its influence on progression-free survival (PFS) in metastatic colorectal canc...

Relationship between cetuximab target-mediated pharmacokinetics and progression-free survival in metastatic colorectal cancer patients

Archive ouverte | Lobet, Sarah | CCSD

International audience. Background and ObjectiveCetuximab, an anti-epidermal growth factor receptor (EGFR) monoclonal immunoglobulin (Ig)G1 antibody, has been approved for the treatment of metastatic colorectal canc...

Chargement des enrichissements...